CA2022420A1 - Vaccin contre escherichia coli - Google Patents

Vaccin contre escherichia coli

Info

Publication number
CA2022420A1
CA2022420A1 CA2022420A CA2022420A CA2022420A1 CA 2022420 A1 CA2022420 A1 CA 2022420A1 CA 2022420 A CA2022420 A CA 2022420A CA 2022420 A CA2022420 A CA 2022420A CA 2022420 A1 CA2022420 A1 CA 2022420A1
Authority
CA
Canada
Prior art keywords
escherichia coli
coli vaccine
found
toxin
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2022420A
Other languages
English (en)
Other versions
CA2022420C (fr
Inventor
Johannes F. Van Den Bosch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of CA2022420A1 publication Critical patent/CA2022420A1/fr
Application granted granted Critical
Publication of CA2022420C publication Critical patent/CA2022420C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CA002022420A 1989-08-18 1990-08-01 Vaccin contre escherichia coli Expired - Lifetime CA2022420C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89.202110.6 1989-08-18
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
CA2022420A1 true CA2022420A1 (fr) 1991-02-19
CA2022420C CA2022420C (fr) 2000-03-28

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022420A Expired - Lifetime CA2022420C (fr) 1989-08-18 1990-08-01 Vaccin contre escherichia coli

Country Status (16)

Country Link
US (1) US5750115A (fr)
EP (1) EP0413378B1 (fr)
JP (1) JP3031561B2 (fr)
KR (1) KR0177510B1 (fr)
CN (1) CN1062605C (fr)
AU (1) AU635062B2 (fr)
CA (1) CA2022420C (fr)
DE (1) DE69016129T2 (fr)
DK (1) DK0413378T3 (fr)
ES (1) ES2070266T3 (fr)
GR (1) GR3015782T3 (fr)
HU (2) HU210965B (fr)
IL (1) IL95175A (fr)
NZ (1) NZ234933A (fr)
TW (1) TW204353B (fr)
ZA (1) ZA906100B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314224B1 (fr) * 1987-10-26 1992-05-27 Akzo N.V. Vaccin contre la septicémie à E.Coli chez la volaille
EP1011440A4 (fr) * 1997-05-16 2003-08-06 Medical Defense Tech Llc Vaccin dirige contre les noyaux de lipopolysaccharides
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
BRPI0615593A2 (pt) 2005-08-30 2011-05-24 Commw Scient And Ind Reseaech Organisation liberação bacteriana de polipeptìdeos biologicamente ativos
AU2010307084B2 (en) 2009-10-12 2015-12-17 Hemanext Inc. Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
CA2781874A1 (fr) 2009-10-12 2011-04-21 New Health Sciences, Inc. Dispositifs d'appauvrissement en oxygene et procedes pour retirer l'oxygene de globules rouges
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
ES2959120T3 (es) 2010-08-25 2024-02-20 Hemanext Inc Método para potenciar la calidad y la supervivencia de glóbulos rojos durante el almacenamiento
EP4218412A1 (fr) 2010-11-05 2023-08-02 Hemanext Inc. Irradiation de globules rouges et stockage anaérobie
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (fr) * 2011-07-11 2013-01-17 Camas Incorporated Compositions contre des toxines bactériennes
PT3061509T (pt) 2011-08-10 2019-09-10 New Health Sciences Inc Depleção de leucócito, oxigénio e/ou co2 integrada e dispositivo de filtro de separação de plasma
ES2900298T3 (es) 2013-02-28 2022-03-16 Hemanext Inc Dispositivo de agotamiento de gas para productos sanguíneos
CA2978940C (fr) 2015-03-10 2023-10-17 New Health Sciences, Inc. Kits jetables de reduction des niveaux d'oxygene, dispositifs et procedes d'utilisation de ceux-ci
KR102661405B1 (ko) 2015-04-23 2024-04-25 헤마넥스트 인코포레이티드 혐기성 혈액 저장 용기
BR122021024410B1 (pt) 2015-05-18 2022-05-03 Hemanext Inc Métodos para gerenciar um banco de sangue e para prover fornecimento de produtos de sangue total armazenados para medicina de transfusão
KR20190017747A (ko) 2016-05-27 2019-02-20 뉴 헬스 사이언시즈 인코포레이티드 혐기성 혈액 저장 및 병원체 불활성화 방법
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
EP0237045B1 (fr) * 1986-03-11 1993-10-20 Shionogi & Co., Ltd. ADN codant pour la flagelline et vecteur le contenant

Also Published As

Publication number Publication date
DK0413378T3 (da) 1995-05-15
AU6109990A (en) 1991-02-21
CN1062605C (zh) 2001-02-28
ZA906100B (en) 1991-05-29
JPH03184996A (ja) 1991-08-12
DE69016129T2 (de) 1995-05-24
ES2070266T3 (es) 1995-06-01
US5750115A (en) 1998-05-12
CN1049523A (zh) 1991-02-27
HU210965B (en) 1995-09-28
DE69016129D1 (de) 1995-03-02
KR0177510B1 (ko) 1999-03-20
EP0413378B1 (fr) 1995-01-18
EP0413378A1 (fr) 1991-02-20
GR3015782T3 (en) 1995-07-31
HUT59612A (en) 1992-06-29
TW204353B (fr) 1993-04-21
HU905053D0 (en) 1991-01-28
IL95175A0 (en) 1991-06-10
IL95175A (en) 1994-05-30
JP3031561B2 (ja) 2000-04-10
HU211827A9 (en) 1995-12-28
CA2022420C (fr) 2000-03-28
NZ234933A (en) 1992-06-25
AU635062B2 (en) 1993-03-11
KR910004209A (ko) 1991-03-28

Similar Documents

Publication Publication Date Title
CA2022420A1 (fr) Vaccin contre escherichia coli
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
CY2570B1 (en) Compounds for immunotherapy and diagnosis of tuberculosis
MX9702955A (es) Vacuna y antitoxina para tratamiento y prevencion de enfermedad c. difficile.
EP1731166A3 (fr) Protéines et vaccins de streptococcus pneumoniae
IL107262A0 (en) Oral vaccines comprising multiple emulsions and methods of preparation
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
CA2014033A1 (fr) Compositions et traitement contre la pneumonie chez les animaux
CA2154063A1 (fr) Traitement de troubles gastroduodenaux associes a h. pylori
CA2145397A1 (fr) Vaccins conjugues polysaccharides-proteines contre des streptocoques du groupe b de types ii et v
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
CA2123222A1 (fr) Vaccins contre des bacteries a gram negatif
TW275632B (fr)
DE69031351T2 (de) Zubereitungen und behandlungen von pneumonia in tieren
CA2109977A1 (fr) Vaccin giardia
CA2097702A1 (fr) Vaccin contre les dermatophyties
CA2133108A1 (fr) Vaccin a base de toxoide contre pasteurella haemolytica type a-1
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
CA2128247A1 (fr) Vaccins bases sur la streptokinase
IL122829A (en) Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
GB9303681D0 (en) Vaccines
ATA211388A (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
RU96123912A (ru) Способ иммунопрофилактики экспериментальной лепрозной инфекции
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry